KRAZATI

Medicinal product

(Invented) name

KRAZATI

Active substance (s)

Adagrasibas

Strength

200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX77, adagrasib

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2024-01-05

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Adagrasibas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112509	98629	1098629	buteliukas	N120		Receptinis	EU/1/23/1744/001	Netiekiama	-	-	No	-	-
112510	98630	1098630	buteliukas	N180		Receptinis	EU/1/23/1744/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-01-05	Registruotas